Share-based Compensation (Tables) |
3 Months Ended |
|---|---|
Dec. 31, 2021 | |
| Share-based Compensation [Abstract] | |
| Recorded Share-Based Compensation Expenses | Three Months Ended December 31, 2021 2020 Cost of sales$ 21,076 $ 16,212Selling, general and administrative 1,395,558 561,484Research and development 463,794 207,601Share-based compensation$ 1,880,428 $ 785,297 |
| Weighted Average Assumptions for Options Granted | Three Months Ended December 31, 2021 2020Weighted Average Assumptions: Expected volatility 77.39% 65.81%Expected dividend yield 0.00% 0.00%Risk-free interest rate 1.33% 0.51%Expected term (in years) 6.0 5.9Fair value of options granted$ 5.60 $ 1.58 |
| Summary of Stock Options Outstanding and Exercisable | Weighted Average Remaining Aggregate Number of Exercise Price Contractual Term Intrinsic Shares Per Share (years) Value Outstanding at September 30, 2021 10,600,680 $ 2.84 Granted 2,207,100 $ 8.35 Exercised (79,334) $ 2.65 Forfeited and expired (1,334) $ 2.25 Outstanding at December 31, 2021 12,727,112 $ 3.79 7.89 $ 38,307,597Exercisable at December 31, 2021 7,441,743 $ 1.82 7.04 $ 30,275,121 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|